ORIC Pharmaceuticals Inc.
(ORIC)
undefined
undefined%
At close: undefined
8.52
0.12%
After-hours Dec 13, 2024, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -100.70M | -89.12M | -78.72M | -73.70M | -26.88M | -21.36M | -22.03M |
| Depreciation & Amortization | 1.03M | 966.00K | 897.00K | 970.00K | 1.03M | 903.00K | 900.00K |
| Stock-Based Compensation | 15.23M | 14.46M | 12.85M | 5.28M | 1.09M | 469.00K | 217.00 |
| Other Working Capital | 1.62M | 1.03M | 1.14M | -2.26M | 234.00K | -297.00K | 89.00K |
| Other Non-Cash Items | -6.15M | -1.00M | 1.35M | 19.84M | 8.00K | 15.00K | 2.00M |
| Deferred Income Tax | - | - | - | 299.00K | - | - | - |
| Change in Working Capital | 4.90M | -445.00K | 4.07M | 2.04M | 1.22M | -707.00K | 95.00K |
| Operating Cash Flow | -85.69M | -75.14M | -59.54M | -45.27M | -23.53M | -20.68M | -20.83M |
| Capital Expenditures | -849.00K | -2.08M | -939.00K | -667.00K | -768.00K | -525.00K | -486.00K |
| Acquisitions | - | 2.08M | 1.38M | - | - | - | - |
| Purchase of Investments | -239.24M | -238.12M | -69.63M | -225.49M | - | - | - |
| Sales Maturities Of Investments | 196.69M | 130.95M | 229.00M | 10.00M | - | - | - |
| Other Investing Acitivies | - | -2.08M | -1.38M | 193.00K | - | 17.00K | 194.00K |
| Investing Cash Flow | -43.40M | -109.25M | 158.44M | -215.96M | -768.00K | -508.00K | -292.00K |
| Debt Repayment | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 1.54M | 225.00K | -866.00K | -20.79M | 70.82M | 38.01M | - |
| Financial Cash Flow | 85.66M | 25.62M | 49.13M | 250.51M | 70.82M | 38.01M | 260.00K |
| Net Cash Flow | -43.43M | -159.17M | 148.03M | -10.71M | 46.52M | 16.82M | -20.86M |
| Free Cash Flow | -86.54M | -77.22M | -60.48M | -45.94M | -24.30M | -21.21M | -21.32M |